These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37371793)

  • 41. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
    Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.
    Wang P; Margolis C; Lin G; Buza EL; Quick S; Raj K; Han R; Giger U
    Vet Pathol; 2018 Mar; 55(2):286-293. PubMed ID: 29157190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical and molecular analysis of mucopolysaccharidoses in Turkey.
    Emre S; Terzioğlu M; Coşkun T; Tokath A; Ozalp I; Müller V; Hopwood J
    Turk J Pediatr; 2002; 44(1):13-7. PubMed ID: 11858372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI.
    Bartolomeo R; Polishchuk EV; Volpi N; Polishchuk RS; Auricchio A
    J Inherit Metab Dis; 2013 Mar; 36(2):363-71. PubMed ID: 22971959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI-LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT).
    Sohn YB; Wang R; Ashworth J; Broqua P; Tallandier M; Abitbol JL; Jozwiak E; Pollard L; Wood TC; Aslam T; Harmatz PR
    Mol Genet Metab Rep; 2024 Mar; 38():101041. PubMed ID: 38234862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses.
    Malinowska M; Jakóbkiewicz-Banecka J; Kloska A; Tylki-Szymańska A; Czartoryska B; Piotrowska E; Wegrzyn A; Wegrzyn G
    Eur J Pediatr; 2008 Feb; 167(2):203-9. PubMed ID: 17361416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.
    Johnson BA; van Diggelen OP; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2013 Oct; 79():17.14.1-17.14.9. PubMed ID: 24510650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
    De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
    Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.
    Kowalewski B; Lamanna WC; Lawrence R; Damme M; Stroobants S; Padva M; Kalus I; Frese MA; Lübke T; Lüllmann-Rauch R; D'Hooge R; Esko JD; Dierks T
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10310-5. PubMed ID: 22689975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R
    Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.
    De Pasquale V; Sarogni P; Pistorio V; Cerulo G; Paladino S; Pavone LM
    Mol Ther Methods Clin Dev; 2018 Sep; 10():8-16. PubMed ID: 29942826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic testing of Mucopolysaccharidoses disease using multiplex PCR- based panels of STR markers: in silico analysis of novel mutations.
    Shafaat M; Hashemi M; Majd A; Abiri M; Zeinali S
    Metab Brain Dis; 2019 Oct; 34(5):1447-1455. PubMed ID: 31236806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the "Gold Standard" Criteria Required to Make a Confirmatory Diagnosis.
    Chuang CK; Lee CL; Tu RY; Lo YT; Sisca F; Chang YH; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Lin HY; Lin SP
    Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover.
    Pohl S; Angermann A; Jeschke A; Hendrickx G; Yorgan TA; Makrypidi-Fraune G; Steigert A; Kuehn SC; Rolvien T; Schweizer M; Koehne T; Neven M; Winter O; Velho RV; Albers J; Streichert T; Pestka JM; Baldauf C; Breyer S; Stuecker R; Muschol N; Cox TM; Saftig P; Paganini C; Rossi A; Amling M; Braulke T; Schinke T
    J Bone Miner Res; 2018 Dec; 33(12):2186-2201. PubMed ID: 30075049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.